Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
AstraZeneca's Imfinzi fails to meet primary endpoint in phase 3 cervical cancer trial
05:23am, Thursday, 24'th Mar 2022
AstraZeneca PLC (LSE:AZN) said an advanced-stage study of its Imfinzi drug failed to meets its target of improving survival in patients with cervical cancer. The CALLA phase 3 trial of Imfinzi (durval
AstraZeneca takes stake in a start-up that helps doctors conduct clinical trials virtually
07:00am, Wednesday, 23'rd Mar 2022
AstraZeneca has taken a roughly £25 million ($33 million) stake in U.K. health start-up Huma, according to a person familiar with the matter.
Liver Drug Saves AstraZeneca Spinoff
05:44pm, Tuesday, 22'nd Mar 2022
A small AstraZeneca ( AZN , Financial) spinoff that was struggling has been revived thanks to what it thinks could become a billion-dollar drug.
Merck (MRK) Keytruda Gets Another FDA Nod in Endometrial Cancer
04:06pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
Merck's (MRK) Keytruda gets approval for advanced endometrial carcinoma therapy in certain patients who are not suited for curative surgery or radiation.
This group of stocks is flagging a rebound, and that's good news for the S&P 500, says technical analyst
01:05pm, Tuesday, 22'nd Mar 2022 MarketWatch
Where is the market going after last week's rally? Our call of the day from MKM's chief strategist is looking at healthy signals from the healthcare sector.
3 Top Biotech Stocks To Watch This Week
12:08pm, Tuesday, 22'nd Mar 2022
Should you be paying attention to these biotech stocks right now?
2 Top Biotech Stocks to Buy Right Now
02:00pm, Monday, 21'st Mar 2022 The Motley Fool
The global pharmaceutical industry grows in importance with each passing year. These two companies are prominent participants.
2 Top Biotech Stocks to Buy Right Now
10:00am, Monday, 21'st Mar 2022
The global pharmaceutical industry grows in importance with each passing year. These two companies are prominent participants.
AstraZeneca ready to drop US approval attempt for Covid vaccine - report
08:07am, Friday, 18'th Mar 2022
AstraZeneca PLC (LSE:AZN) is ready to drop attempts to get its Covid-19 vaccine approved in the US, according to reports last night. Sir Mene Pangalos, AstraZeneca's head of research and development,
AstraZeneca, Merck's Lynparza Cut Risk of Breast Cancer Death
05:15pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Treatment with AstraZeneca (AZN) and Merck's (MRK) Lynparza show meaningful improvement in overall survival for patients with BRCA-mutated HER2-negative high-risk early breast cancer.
AstraZeneca, Merck's Lynparza Cut Risk of Breast Cancer Death
02:18pm, Thursday, 17'th Mar 2022
Treatment with AstraZeneca (AZN) and Merck's (MRK) Lynparza show meaningful improvement in overall survival for patients with BRCA-mutated HER2-negative high-risk early breast cancer.
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
11:53am, Thursday, 17'th Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
AbbVie's Rinvoq Gets Label Expansion To Treat Ulcerative Colitis
AbbVie, Inc. (NYSE: ABBV) announced
AstraZeneca to pay $775M to Roche''s unit Chugai to settle Ultomiris patent litigation
09:34am, Thursday, 17'th Mar 2022 Seeking Alpha
AstraZeneca (AZN) will pay $775M to Roche''s (RHHBY) (RHHBF) unit Chugai Pharmaceutical (CHGCF) to resolve all patent disputes related to rare disease drug Ultomiris.AstraZeneca…
AstraZeneca''s Evusheld gets approval in UK to prevent COVID-19 (NASDAQ:AZN)
09:10am, Thursday, 17'th Mar 2022 Seeking Alpha
U.K.''s Medicines and Healthcare products Regulatory Agency ((MHRA)) approved AstraZeneca''s (AZN) antibody cocktail Evusheld for preventing COVID-19.MHRA said the decision to grant…
AstraZeneca's COVID vaccine alternative gets UK green light
09:08am, Thursday, 17'th Mar 2022
AstraZeneca PLC (LSE:AZN)'s preventative treatment for COVID-19 has been approved by the UK medical regulator, as an alternative for people for whom vaccines are not effective. The new medicine, Evush
